Analysts think NCNA stock price could increase by 3145%
Sep 27, 2024, 11:25 AM
-34.91%
What does NCNA do
NuCana PLC is a UK-based biopharmaceutical company focused on cancer treatments using ProTide technology, with candidates NUC-3373 and NUC-7738 currently in Phase I/II clinical trials. The company's pipeline also includes Acelari, a ProTide transformation of gemcitabine.
4 analysts think NCNA stock price will increase by 3145.45%. The current median analyst target is $89.25 compared to a current stock price of $2.75. The lowest analysts target is $25.25 and the highest analyst target is $157.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.